Validation and comparison between current prognostication systems for pancreatic neuroendocrine neoplasms: A?single-institution experience with 176 patients.

Find People
Find Everything
About This Site
Edit My Profile
Login to Profiles
DIRECT2Experts
Help / FAQ

History

Anti-pathogenic activi

Clinical characteristi

Outcomes of commercial

Outcomes of Open vs En

Validation and compari

See All (6) pages

Announcement

You can now add alternative names! Click here to add other names that you've published under.

Validation and comparison between current prognostication systems for pancreatic neuroendocrine neoplasms: A?single-institution experience with 176 patients.

Teo R, Goh BKP, Tai DWM, Allen JC, Lim TKH, Hwang JSG, Tan DM, Lee SY, Chan CY, Cheow PC, Chow PKH, Ooi LLPJ, Chung AYF, Ong S. Validation and comparison between current prognostication systems for pancreatic neuroendocrine neoplasms: A?single-institution experience with 176 patients. Surgery. 2017 05; 161(5):1235-1245.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Female
Humans
Male
Middle Aged
Neoplasm Grading
Neoplasm Staging
Neuroendocrine Tumors
Pancreatic Neoplasms
Prognosis
Reproducibility of Results
Retrospective Studies
Survival Rate